Boehringer Ingelheim Vetmedica, Inc. Newsroom

Click here for the latest news releases from Boehringer Ingelheim’s U.S. Animal Health Business. See below for news releases from 2013 through 2018

12.12.2018: Boehringer Ingelheim Announces Winners of 2018 Champions of the Cause Awards
10.02.2018: Introducing SEMINTRA® (telmisartan oral solution) —The First FDA-Approved Liquid Solution For Feline Hypertension
09.12.2018: Boehringer Ingelheim to Donate 75,000 Doses of Rabies Vaccine to the Global Alliance for Rabies Control Through Shots for Good Initiative
09.05.2018: Researchers focused on infectious respiratory disease in pigs may apply for Boehringer Ingelheim research awards
08.27.2018: FDA approves NexGard® (afoxolaner) for the prevention of infections that cause Lyme disease in dogs

Page content